Subjectively perceived personality and mood changes associated with subthalamic stimulation in patients with Parkinson's disease.

Lewis CJ, Maier F, Horstkötter N, Zywczok A, Witt K, Eggers C, Meyer TD, Dembek TA, Maarouf M, Moro E, Zurowski M, Woopen C, Kuhn J, Timmermann L.

Psychol Med. 2015 Jan;45(1):73-85. doi: 10.1017/S0033291714001081.

The effects of uric Acid, serum vitamin d3, and their interaction on Parkinson's disease severity.

Meamar R, Shaabani P, Tabibian SR, Aghaye Ghazvini MR, Feizi A.

Parkinsons Dis. 2015;2015:463483. doi: 10.1155/2015/463483.

Polymorphism in the Vesicular Monoamine Transporter 2 Gene Decreases the Risk of Parkinson's Disease in Han Chinese Men.

Yang X, Xu P, Zhao Q, An R, Jia H, Liu Z, Xu Y.

Parkinsons Dis. 2015;2015:903164. doi: 10.1155/2015/903164.

Molecular interaction studies of green tea catechins as multitarget drug candidates for the treatment of Parkinson's disease: computational and structural insights.

Azam F, Mohamed N, Alhussen F.

Network. 2015;26(3-4):97-115. doi: 10.3109/0954898X.2016.1146416.

Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review.

Kulkarni AD, Vanjari YH, Sancheti KH, Belgamwar VS, Surana SJ, Pardeshi CV.

J Drug Target. 2015;23(9):775-88. doi: 10.3109/1061186X.2015.1020809. Review.

Transiently impaired neurogenesis in MPTP mouse model of Parkinson's disease.

He XJ, Nakayama H.

Neurotoxicology. 2015 Sep;50:46-55. doi: 10.1016/j.neuro.2015.07.007.

Genetic association of cyclooxygenase-2 gene polymorphisms with Parkinson's disease susceptibility in Chinese Han population.

Dai Y, Wu Y, Li Y.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13495-9.

The Natural History of Depression in Parkinson's Disease within 30-Month Follow-Up.

Xu YY, Kuo SH, Liang Z, Xu H, Feng WR, Yu CY, Liu WG.

Parkinsons Dis. 2015;2015:362892. doi: 10.1155/2015/362892.

Protective Effects of Physical Exercise in Alzheimer's Disease and Parkinson's Disease: A Narrative Review.

Paillard T, Rolland Y, de Souto Barreto P.

J Clin Neurol. 2015 Jul;11(3):212-9. doi: 10.3988/jcn.2015.11.3.212. Review.

Graphical Tasks to Measure Upper Limb Function in Patients with Parkinson's Disease: Validity and Response to Dopaminergic Medication.

Smits EJ, Tolonen AJ, Cluitmans L, Van Gils M, Zietsma RC, Borgemeester RW, van Laar T, Maurits NM.

IEEE J Biomed Health Inform. 2015 Nov 25. [Epub ahead of print]

Sequential movement skill in Parkinson's disease: a state-of-the-art.

Ruitenberg MF, Duthoo W, Santens P, Notebaert W, Abrahamse EL.

Cortex. 2015 Apr;65:102-12. doi: 10.1016/j.cortex.2015.01.005. Review.

Abnormal Olfaction in Parkinson's Disease Is Related to Faster Disease Progression.

Cavaco S, Gonçalves A, Mendes A, Vila-Chã N, Moreira I, Fernandes J, Damásio J, Teixeira-Pinto A, Bastos Lima A.

Behav Neurol. 2015;2015:976589. doi: 10.1155/2015/976589.

Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease.

Divito CB, Steece-Collier K, Case DT, Williams SP, Stancati JA, Zhi L, Rubio ME, Sortwell CE, Collier TJ, Sulzer D, Edwards RH, Zhang H, Seal RP.

J Neurosci. 2015 Nov 11;35(45):14983-99. doi: 10.1523/JNEUROSCI.2124-15.2015.

Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study.

Pellecchia MT, Picillo M, Santangelo G, Longo K, Moccia M, Erro R, Amboni M, Vitale C, Vicidomini C, Salvatore M, Barone P, Pappatà S.

Acta Neurol Scand. 2015 May;131(5):275-81. doi: 10.1111/ane.12365.

No evidence for substrate accumulation in Parkinson brains with GBA mutations.

Gegg ME, Sweet L, Wang BH, Shihabuddin LS, Sardi SP, Schapira AH.

Mov Disord. 2015 Jul;30(8):1085-9. doi: 10.1002/mds.26278.